Earnings call: Getinge reports steady Q1 growth, maintains full-year outlook
Getinge AB (GETI B), a leading global provider of medical technology products and solutions, reported a 5.2% increase in sales for the first quarter of 2024, with a steady organic sales performance despite previous year's high comparative figures from COVID-19 impacts in China. The company's order intake rose by 7.8%, showing organic growth across all business areas and regions.